Cyclobenzaprine

Generic Name
Cyclobenzaprine
Brand Names
Amrix, Fexmid, Flexeril
Drug Type
Small Molecule
Chemical Formula
C20H21N
CAS Number
303-53-7
Unique Ingredient Identifier
69O5WQQ5TI
Background

Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961 and has been available for human use since 1977. It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressants - it differs from Amitriptyline by only a single double bond. Since its approval, it has remained relatively popular...

Indication

用于缓解与急性疼痛的肌肉骨骼疾病相关的肌肉痉挛(作为休息和物理治疗的辅助药)。但环苯扎林对脑、脊髓疾病或儿童脑性瘫痪引起的痉挛无效。

Associated Conditions
Muscle Spasms
Associated Therapies
-

Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study

First Posted Date
2021-02-25
Last Posted Date
2023-04-27
Lead Sponsor
Prisma Health-Midlands
Target Recruit Count
72
Registration Number
NCT04771741
Locations
🇺🇸

Prisma Health Midlands, Columbia, South Carolina, United States

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction

First Posted Date
2017-04-25
Last Posted Date
2023-02-09
Lead Sponsor
Apsen Farmaceutica S.A.
Target Recruit Count
140
Registration Number
NCT03127592
Locations
🇧🇷

Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda., Valinhos, São Paulo, Brazil

Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine in Osteomuscular Treatment

First Posted Date
2017-01-19
Last Posted Date
2021-02-24
Lead Sponsor
EMS
Target Recruit Count
416
Registration Number
NCT03025113
Locations
🇧🇷

Allegisa, Campinas, São Paulo, Brazil

Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis

First Posted Date
2015-12-30
Last Posted Date
2018-01-03
Lead Sponsor
Tanta University
Target Recruit Count
200
Registration Number
NCT02642861
Locations
🇪🇬

Tanta university - faculty of medicine, Tanta, Egypt

Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

First Posted Date
2013-08-13
Last Posted Date
2016-04-20
Lead Sponsor
Lynn Henry
Target Recruit Count
2
Registration Number
NCT01921296
Locations
🇺🇸

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

A Randomized Study of Three Medication Regimens for Acute Low Back Pain

First Posted Date
2012-04-30
Last Posted Date
2018-07-31
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
323
Registration Number
NCT01587274
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Use of Cyclobenzaprine After Vaginal Surgery

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-03-05
Last Posted Date
2019-09-10
Lead Sponsor
NorthShore University HealthSystem
Target Recruit Count
63
Registration Number
NCT01081990
Locations
🇺🇸

Evanston NorthShore University HealthSystem, Evanston, Illinois, United States

Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters

First Posted Date
2009-12-09
Last Posted Date
2012-06-08
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
56
Registration Number
NCT01028014
Locations
🇺🇸

University of Alabama at Birmingham, The Kirklin Clinic, Birmingham, Alabama, United States

Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial

First Posted Date
2008-11-13
Last Posted Date
2012-11-21
Lead Sponsor
Stony Brook University
Target Recruit Count
61
Registration Number
NCT00790270
Locations
🇺🇸

Stony Brook University, Stony Brook, New York, United States

© Copyright 2024. All Rights Reserved by MedPath